An announcement from Genor Biopharma Holdings Limited ( (HK:6998) ) is now available.
Genor Biopharma Holdings Limited, a company incorporated in the Cayman Islands, held an Extraordinary General Meeting (EGM) on February 19, 2025, where all proposed resolutions were unanimously passed. The key decision from the EGM was the removal of PwC as the Company’s auditor and the immediate appointment of EY to the position. This change in auditors may signal a strategic shift or a response to specific business needs, impacting the company’s operational strategies and possibly influencing stakeholder perception.
More about Genor Biopharma Holdings Limited
YTD Price Performance: -2.63%
Average Trading Volume: 1,654
Technical Sentiment Consensus Rating: Hold
Current Market Cap: €109.5M
See more insights into 6998 stock on TipRanks’ Stock Analysis page.